OSI Systems Inc (NASDAQ: OSIS) — Backlog Is Real; Cash Returns Need Proof

Published: 2026-09-14 · Verdict: Hold · Entry price: $175 · Price target: $235 · Research confidence: High (82%)

Executive conclusion

Analyst Take

OSI Systems merits a HOLD at the September 14, 2026 closing price of $199.95, with a $235 twelve-month price target and a preferred $170-$180 entry zone, represented by $175 in the metadata. The recommendation reflects a tension between a genuinely differentiated Security franchise and cash returns that remain less dependable than the backlog, adjusted earnings, and service-growth narrative imply.

The verified operating case is strong. Fiscal 2026 revenue was $1.786 billion, GAAP operating income was $219.0 million, and diluted GAAP EPS was $8.95. Security generated $1.248 billion, or 69.9% of external revenue, and $208.5 million of segment income before separately presented charges. Consolidated service revenue grew 13.2% to $441.3 million and earned a 43.8% gross margin, compared with 29.7% for products. Management reports more than 100,000 installed Security systems across more than 170 countries and a $1.9 billion backlog. The latest calls also identified specific demand rather than a generic macro story: approximately $50 million of delayed Middle East deliveries, two Customs and Border Protection contract vehicles with $285 million of combined ceilings, a $235 million over-the-horizon-radar award, aviation replacement demand, and continued double-digit service ambitions. [S1] [S2] [S4] [S6]

The valuation reset is also real. The stock is 35.9% below its April 2026 intraday high and close to the bottom of its trailing-52-week range. At $199.95, it trades at approximately 22.3 times fiscal 2026 GAAP EPS, 19.3 times fiscal 2026 adjusted EPS, 17.7 times midpoint fiscal 2027 adjusted-EPS guidance, and 14.6 times trailing EBITDA. Those figures no longer price uninterrupted execution, but they still require successful delivery of management’s second-half-weighted fiscal 2027 plan and better through-cycle cash conversion. The completed Smiths Detection sale at 12.5 times EBITDA is useful corroboration that comparable security assets have strategic value, not a guaranteed valuation floor for OSI’s consolidated equity. [S2] [S7] [S9]

The central variant perception is that investors may be correctly underwriting end demand while still overestimating the quality of each reported earnings dollar. Fiscal 2026 operating cash flow reached $275.9 million, but receivables supplied $98.7 million of that amount after consuming $458.4 million over fiscal 2024-2025. Across fiscal 2024-2026, cumulative net income was $432.5 million, whereas cumulative operating cash flow was $286.0 million and cumulative free cash flow after ordinary capital expenditure was only $209.5 million. Part of the deficit represents recoverable financing of a large Mexican security program, rather than destroyed economics. Even so, the one-year 7.7% free-cash-flow yield is not a clean recurring yield. A reasonable but necessarily uncertain normalized range is $150-$190 million, equivalent to approximately 4.7%-6.0% of current equity value. [S1] [S4]

Capital allocation prevents a higher-conviction rating. OSI repurchased 1.11 million shares for $271.9 million during fiscal 2026, an estimated average of $244.55, while issuing $575 million of 0.5% convertible notes and ending with approximately $1.00 billion of debt. The share count fell materially, so these were economically meaningful buybacks rather than mere anti-dilution. Nevertheless, the average purchase price was 22% above the current price, and the annual incentive plan’s adjusted-return-on-equity metric can improve mechanically when debt-funded repurchases reduce equity. The low coupon is favorable, but a convertible remains debt plus a contingent equity claim, not costless capital. [S1] [S3]

The strongest counter-case is that this framing understates the remaining Mexico cash release and undervalues Security’s installed-base economics. Management says the delayed Middle East work remains in backlog, expects fiscal 2027 free cash flow to exceed net income, and guides to 5.0%-8.1% revenue growth and 7.5%-11.0% adjusted-EPS growth. If service grows at least 10%, the Mexican receivable declines without replacement working-capital pressure, the RF program is definitized without a loss, and Healthcare sustains rather than merely touches a better margin, the current valuation can support attractive returns. [S2] [S4]

Investment conviction is moderate, and evidence quality is uneven by question. Audited revenue, margins, debt, cash flow, and repurchases are high-confidence facts. Backlog conversion, recurring-service composition, acquired-RF returns, and normalized free cash flow are estimates or management hypotheses. The near-term decision sequence is therefore concrete: watch Middle East conversion, quarterly receivables and Mexico collections, firm CBP task orders rather than IDIQ ceilings, RF definitization and milestones, service growth alongside margin and capital employed, Healthcare’s full-year margin, and repurchase prices. The call would improve with at least $180 million of free cash flow without another material receivables build, Security service growth above 10%, Healthcare margins above 6% over four quarters, and net debt below two times unadjusted EBITDA before another large repurchase wave. It would deteriorate if delayed orders leave backlog, Security margin falls below 14.5%, cumulative cash conversion remains below 85% of net income, or debt-financed repurchases continue above independently supportable value.

Stock Price Action — Five-Year Event Map

Company Financials’ split-adjusted series places the five-year intraday low at $69.31 on October 13, 2022 and the high at $311.72 on April 21, 2026. The September 14, 2026 close was $199.95. The stock is therefore 188% above its five-year low, 35.9% below its high, and only 10.7% of the way from its $186.50 to $311.72 trailing-52-week range. From the $93.30 close on September 14, 2021, the five-year gain was approximately 114%, or 16.5% annualized. Price observations are facts; explanations for individual moves remain interpretations unless directly supported by contemporaneous disclosures. [S7]

• August 19, 2022: down 7.2% to $94.80. The move followed fiscal 2022 results. Revenue had grown only 3.2%, and the period included a broader risk-off decline that later pushed the stock below $70. The audited record also shows that fiscal 2022 net income benefited from a $27.4 million real-estate sale gain, so the apparent EPS growth was not wholly operating. It would be excessive to attribute the entire daily decline to that item or to company fundamentals alone. [S18]

• August 24, 2023: up 13.7% to $136.69. Fiscal fourth-quarter revenue grew 22%, backlog increased 46% to $1.8 billion, and management guided to more than 18% fiscal 2024 revenue growth and more than 25% adjusted-EPS growth. The temporal relationship is strong, although the market’s allocation of the move among backlog, guidance, Security growth, and margins cannot be observed directly. [S18]

• August 22, 2024: up 6.7% to $154.28. The move followed fiscal-year results during the ramp of the Mexican turnkey program. Audited fiscal 2024 revenue ultimately rose 20.4% to $1.539 billion, but operating cash flow was negative $87.5 million because receivables expanded sharply. The price response shows that the market initially rewarded earnings growth even though the associated financing burden remained unresolved. [S1] [S7]

• January 23, 2025: up 14.2% to $193.05. Fiscal second-quarter results and increased expectations accelerated the re-rating shortly after Ajay Mehra became chief executive. The operating update plausibly drove the move, but the price record cannot prove that the leadership transition caused the performance. [S7] [S13]

• October 31, 2025: up 14.2% to $278.46. Fiscal 2026 first-quarter results extended enthusiasm for backlog, Security growth outside Mexico, and RF opportunities. The subsequent rise above $300 indicates that investors capitalized considerable future execution before full cash conversion had been demonstrated. [S7] [S16]

• January 30, 2026: down 7.3% to $250.14. The preceding release reported record second-quarter revenue and increased adjusted-EPS guidance. A negative reaction to favorable headline results is consistent with elevated expectations, mix concerns, or valuation sensitivity, but price alone cannot distinguish among those explanations. [S7] [S16]

• May 5, 2026: down 17.0% to $234.74. The prior evening’s results included record third-quarter revenue, 1.3 times book-to-bill, and $1.9 billion of backlog. Management also discussed sharply lower Mexico revenue, a Department of Homeland Security funding interruption, service-growth variability, and RF execution timing. The largest one-day decline in the five-year series demonstrates that backlog growth did not satisfy investors seeking near-term conversion, although the exact causal weights remain inferential. [S5] [S7]

• August 21, 2026: down 5.2% to $206.73, after an intraday low of $186.50. Fiscal fourth-quarter revenue declined 4% because management said approximately $50 million of planned Middle East deliveries moved beyond June. Fiscal 2027 guidance remained positive but was second-half weighted. The market reaction is consistent with reduced confidence in timing rather than evidence that the underlying orders were cancelled. [S2] [S4] [S7]

The event map revalidates a transferable analytical rule: after a major price gap, valuation percentiles must be recomputed rather than inherited. The fall from $311.72 to $199.95 reduced the forward adjusted-earnings multiple to 17.7 times. It did not create a distressed normalized-cash-flow valuation, because the earnings denominator still assumes successful fiscal 2027 execution and reported fiscal 2026 free cash flow contained a major working-capital release. [S1] [S2] [S7]

Verdict: The five-year record contains a genuine fundamental re-rating through 2025 and an expectations reset in 2026. The drawdown improves prospective returns, but repeated double-digit reactions to contract timing and guidance show that backlog does not remove quarterly event risk.

Business Overview

OSI Systems is a Delaware corporation whose common stock trades directly on Nasdaq. It is an ordinary U.S. C-corporation, not an ADR, partnership, MLP, trust, or K-1 issuer. Economically, it is three businesses connected by electronics engineering, manufacturing, procurement, and selected technologies: a Security systems-and-services franchise, an engineered-components and contract-manufacturing operation, and a smaller patient-monitoring business. [S1]

The business is readily understandable at the driver level even though contract accounting and working capital make quarterly results difficult to forecast. Revenue depends on equipment volume and mix, project milestones, customer acceptance, service attachment and renewal, checkpoint-operation volumes, RF-program execution, OEM demand, medical capital budgets, pricing, and acquisitions. Cash generation adds advance payments, inventory builds, construction or installation work, bill-and-hold arrangements, unbilled revenue, receivable collection, and sovereign-customer timing. The same contract may therefore create economic value while moving reported revenue and cash into different periods. [S1]

Security: the economic core

Security generated $1.248 billion of external fiscal 2026 revenue, 69.9% of consolidated revenue. Rapiscan supplies systems that inspect baggage, parcels, cargo, vehicles, people, mail, and infrastructure for weapons, explosives, narcotics, radioactive material, and other contraband. S2 Global adds site design, installation, integration, training, staffing, checkpoint operation, and long-term turnkey services. CertScan integrates information from OSI and third-party equipment. The acquired RF platform supplies high-power transmission, surveillance, scientific, and defense systems. Direct U.S. government sales were $207.3 million, but airports, customs agencies, border crossings, ports, defense agencies, and private operators create a broader customer base. [S1] [S6]

The customer value proposition is operational rather than cosmetic. Better detection can lower false alarms and secondary inspections, improve passenger or cargo throughput, and reduce labor requirements. Reliability matters because an unavailable scanner can constrain an entire checkpoint or border lane. Certification, software integration, field service, replacement parts, and operator training determine whether a technically capable product works in a live environment. A turnkey contract can transfer operating complexity to OSI, while RF products may perform mission-critical communications or surveillance functions.

The outcome appears in segment economics. Fiscal 2026 Security income before separately presented restructuring and related charges was $208.5 million, a 16.7% margin. Management’s adjusted presentation, which also removes acquired-intangible amortization, produced a 17.9% margin. Security generated roughly 88% of the three reportable segments’ income despite accounting for less than that proportion of segment revenue once Optoelectronics intersegment sales are included. [S1] [S2]

Security revenue is not uniformly recurring. Management classifies approximately 31% as recurring, principally field service, turnkey operations, consumables, and some software. That is a management taxonomy, not an audited measure of contractual annual recurring revenue. Maintenance and software can be stable, but installation, staffing, and security-as-a-service may require project capital or vary with operating volumes. Hardware, site projects, RF programs, and customer acceptances remain transactional. The $1.9 billion backlog equals approximately 1.06 times fiscal 2026 consolidated revenue, but orders can be rescheduled or cancelled, and government contracts may be terminated for convenience. [S1] [S6]

Optoelectronics and Manufacturing

Optoelectronics generated $375.3 million of external revenue, 21.0% of consolidated revenue, plus $75.5 million of intersegment revenue. It designs photodetectors, optoelectronic devices, flex circuits, subassemblies, and high-reliability electronics and provides manufacturing services to defense, aerospace, medical, communications, industrial, computing, and consumer customers. Internal supply to Security and Healthcare provides a degree of vertical integration. Fiscal 2026 segment income was $57.6 million on $450.8 million of revenue including intersegment activity, a 12.8% margin before separately presented charges. Calculating the margin only on external revenue would overstate economics because the segment incurs costs to supply sister divisions. [S1]

Management calls more than 85% of Optoelectronics revenue repeat revenue. Repeat production during an OEM platform’s life is valuable, but it is not equivalent to a subscription or enforceable long-term volume. Customers can lose market share, redesign products, dual-source, reduce inventories, or discontinue a platform. The moat mechanism is engineering qualification, process quality, delivery reliability, and integration into customer designs. Labor-intensive manufacturing in Mexico, India, Indonesia, and Malaysia provides a cost response to offshore competitors, while specialized engineering and reliability distinguish the segment from pure commodity assembly. [S1] [S6]

The closest cataloged same-industry report, Sanmina, highlights a useful contradiction to simplistic electronic-components comparisons. Large contract manufacturers can report very high repeat business while earning thin margins and carrying substantial customer and working-capital exposure. OSI’s Optoelectronics margin is materially higher than a commodity EMS profile, but its intersegment sales, engineered mix, and much smaller scale mean neither Sanmina’s low-margin structure nor its valuation can be transferred mechanically. The comparison instead sharpens the questions: how much of OSI’s margin comes from proprietary engineering, what arm’s-length return is earned on internal supply, and how much capital repeat OEM programs consume. Those questions are tested against OSI’s filings and not answered by a peer label. [S1]

Healthcare

Healthcare generated $162.7 million, or 9.1% of fiscal 2026 revenue. Spacelabs sells patient-monitoring systems, diagnostic cardiology equipment, remote-monitoring products, connected-care software, accessories, supplies, and service, principally to hospitals. An installed base can create replacement, maintenance, consumables, and software revenue. Management classifies more than 45% of the division’s revenue as recurring. Clinical workflow integration, alarm settings, device connectivity, and staff familiarity can create retention. [S1] [S6]

The financial record does not establish a strong Healthcare moat. Fiscal 2026 revenue declined 3.3%, and segment income before separately presented charges was only $6.9 million, a 4.2% margin. After allocated charges, GAAP segment profit was approximately zero. Management highlighted a 10% adjusted fourth-quarter margin after new leadership and cost actions, but explicitly cautioned investors against extrapolating that quarter. A single improved quarter is evidence of potential operating leverage, not proof of durable return. [S1] [S2] [S4]

Revenue stability and concentration

Revenue stability is moderate, not subscription-like: service revenue was 24.7% of fiscal 2026 sales and carried attractive margins, but most revenue remained products, projects, RF programs, and OEM orders whose timing can be volatile. Consolidated service revenue rose from $389.9 million to $441.3 million, while products increased from $1.323 billion to $1.345 billion. The service mix improved, but public disclosure does not separate maintenance, subscriptions, installation, training, staffing, and turnkey operations. [S1]

No customer exceeded 10% of fiscal 2026 revenue, which reduces dependence on a single annual sales source. Cash concentration was much higher: one Security customer represented 25% of year-end receivables, down from 42% the preceding year. Net accounts receivable remained $764.6 million, equal to 42.8% of annual revenue, and unbilled revenue was $190.9 million. The concentration decline is favorable, but the remaining balance shows why diversified revenue does not automatically produce diversified cash collection. [S1] [S4]

Unrecognized assets and economic liabilities

The most important economically valuable assets not fully recognized on the balance sheet are installed equipment, regulatory qualifications, tender references, field-service infrastructure, software and algorithms, engineering know-how, customer relationships, and the Rapiscan, S2, Spacelabs, and OSI Electronics reputations. Internally created technology and customer trust are largely expensed through research, selling, and service costs. Acquired relationships, technology, and trademarks contributed to $192.4 million of recorded intangible assets, while $406.7 million of goodwill represented acquisition premiums. [S1]

Those hidden assets have a corresponding analytical caution. An installed base is valuable only if service attachment, retention, pricing, and cash returns remain strong. Certifications matter only while products continue satisfying evolving standards. Goodwill is not evidence that acquisitions created value. Likewise, management’s claimed leadership in cargo and vehicle non-intrusive inspection is plausible but not independently substantiated by disclosed market-share data. [S6]

Verdict: OSI is understandable as a Security-led systems-and-services company with two smaller electronics businesses. Security’s installed base, certification, integration, and service infrastructure appear economically valuable. Nevertheless, backlog, repeat revenue, and management-defined recurring revenue should not be treated as annuities without cohort-level retention, margin, and cash evidence.

Industry Dynamics

OSI does not operate in one homogeneous market. Its principal profit pool is security screening and threat detection; secondary exposures include high-power RF systems, engineered electronics and contract manufacturing, and patient monitoring. A consolidated electronic-components classification is therefore analytically weak. Rapiscan competes with Smiths Detection, Leidos Security Enterprise Solutions, Nuctech, Analogic, Teledyne FLIR, and modality-specific vendors. Optoelectronics competes with component specialists and contract manufacturers. Healthcare faces much larger medical-device companies capable of bundling monitors, informatics, service, and hospital-wide procurement.

Market size, geography, and demand evidence

There is no defensible single public total-addressable-market figure for the entire company because cargo scanners, airport checkpoints, defense RF, medical monitoring, and contract manufacturing have different customer sets and economics. A precise consolidated TAM would create false confidence. The more useful evidence consists of observable appropriations, deployment shortfalls, competitor scale, installed fleets, replacement cycles, and OSI’s own addressable contract vehicles.

The U.S. border opportunity is tangible. The Government Accountability Office reported that Customs and Border Protection received more than $2.1 billion for its large-scale non-intrusive-inspection program over fiscal 2019-2024. Of 153 planned systems, only 52 were fully operational as of February 2025; 101 remained in preplanning, design, or construction. An earlier CBP estimate contemplated 434 systems for fuller scanning, including 281 potential future procurements. The same report supplies the bear evidence: deployments were delayed by site constraints, construction, power and data requirements, staffing, testing, equipment availability, and vendor issues, and completion was not expected until December 2029. Appropriated need is not equivalent to prompt revenue. [S11]

Aviation offers replacement and expansion demand as airports move toward computed-tomography systems, automated threat recognition, higher throughput, and integrated checkpoint software. Smiths Detection reported about 1,800 CTiX systems sold by fiscal 2025, 23.4% organic aviation growth, and 19.6% aftermarket growth. That record corroborates healthy sector demand while simultaneously demonstrating that OSI faces a capable, scaled rival with a large installed base. [S8]

High-power RF adds defense, surveillance, scientific, communications, and over-the-horizon-radar opportunities. OSI’s $235 million undefinitized, not-to-exceed award validates customer interest, but it is not a final fixed price or disclosed profit stream. Technical milestones, government funding, security requirements, capacity investment, and contract definitization can create significant timing and margin variation. [S4] [S5]

Demand is international. Fiscal 2026 revenue classified by selling entity was approximately 49.7% Americas, 32.5% Europe, the Middle East and Africa, and 17.7% Asia-Pacific. This is not a precise end-customer demand map because legal selling entities can transact across borders. International reach diversifies budgets and programs, but it adds licensing, sanctions, currency, local-content, logistics, tax, conflict, and sovereign-payment risks. The delayed Middle East deliveries provide a current example: demand may remain commercially valid while site access prevents shipment or installation. [S1] [S4]

Profit pools and barriers to entry

Security screening has meaningful barriers. Products must meet detection, radiation, safety, cybersecurity, and procurement standards. Live airport and border environments require evidence of throughput, false-alarm performance, reliability, serviceability, and integration. Government buyers demand bid qualifications, references, security clearances, performance bonds, and long support lives. Developing a scanner is insufficient; a challenger also needs certification, field technicians, spares, software, installation capacity, tender references, and customer trust.

The strongest profit pool is generally the installed-base aftermarket and integrated service layer. Certified equipment produces repair, parts, software, training, consumable, and renewal demand. OSI’s consolidated service gross margin was 43.8%, fourteen percentage points above products. Smiths Detection obtained 51% of fiscal 2025 revenue from aftermarket. Those independent company observations support the mechanism that installed equipment can create higher-margin follow-on economics. They do not prove that every item OSI labels service is recurring maintenance. [S1] [S8]

Industry profitability is attractive for differentiated incumbents but uneven: OSI Security produced a 16.7% pre-charge segment margin, Smiths Detection reported a 12.7% headline operating margin, OSI Optoelectronics earned 12.8% including intersegment revenue, and OSI Healthcare earned only 4.2% before separately presented charges. Barriers protect particular certifications, platforms, relationships, and service networks; they do not protect every dollar of hardware or manufacturing revenue. [S1] [S8]

The weaker pools include price-led tenders, commoditizing hardware, low-differentiation contract manufacturing, and project work with substantial vendor financing. Turnkey contracts can generate long relationships and high nominal service revenue, but returns depend on equipment ownership, advances, staffing, receivables, guarantees, and renewal pricing. A service label by itself does not establish asset-light economics.

Competitive intensity and the capital cycle

The industry is becoming larger and technologically richer, but not necessarily less competitive. Smiths Detection generated £963 million of fiscal 2025 revenue, £122 million of headline operating profit, and a 51% aftermarket mix. Leidos markets checked-baggage and checkpoint equipment, open-architecture software, automated-tray systems, and global service. Nuctech competes internationally across cargo, baggage, and border applications. Established electronics, defense, medical, and software vendors can invest when government appropriations and replacement programs expand. [S8] [S10] [S12]

A supply-side capital-cycle lens produces a mixed conclusion. Certification and long qualification periods restrain casual entry, preserving incumbent economics. Yet visible government funding attracts capable strategic and financial capital. CVC’s completed acquisition of Smiths Detection could sharpen commercial discipline and investment. Open architectures may allow software and integration specialists to capture value above proprietary hardware. AI-assisted image analysis could improve incumbent systems, but it may also reduce hardware lock-in if algorithms become more portable. [S9]

OSI has a useful response through CertScan, which management says integrates third-party equipment. That capability could let OSI participate in workflow and data economics even when it does not supply every scanner. The tradeoff is that interoperability can weaken a hardware vendor’s switching costs. Whether open architecture is a moat enhancer or moat eroder depends on who controls the customer interface, data, upgrades, and service agreement.

Foreign low-cost and subsidized competition

Foreign low-cost production can undermine portions of the business, especially standardized electronics and price-sensitive scanner tenders, but OSI has partly internalized the response. Labor-intensive high-volume manufacturing occurs in Mexico, India, Indonesia, and Malaysia, giving the company a lower-cost footprint. Certification, security considerations, export controls, service coverage, and procurement rules further limit substitution based only on labor cost. [S1]

The threat nevertheless remains material. In December 2025, the European Commission opened an in-depth investigation into whether Nuctech benefited from Chinese grants, preferential tax treatment, and financing that could support distorted tender terms. The Commission emphasized that opening the investigation did not prejudge the outcome. This is evidence of a potential pricing mechanism, not a legal finding that Nuctech committed wrongdoing. It can hurt Western incumbents through aggressive bidding, while any eventual procurement remedy could improve their competitive position. [S12]

Adjacent-market cycles

Healthcare demand benefits from aging populations, monitoring intensity, connectivity, and hospital replacement needs. Hospital labor inflation, constrained capital budgets, and large-vendor bundling can delay or redirect purchases. OSI’s smaller scale may support focus, but it limits procurement leverage, distribution breadth, and R&D scale relative to larger medical-device competitors.

Optoelectronics participates in aerospace, defense, medical, industrial, and communications programs. Engineering qualification can produce long product lives and repeat orders. However, OEM inventory corrections, end-product transitions, redesigns, and dual sourcing create cyclicality. Jabil or Sanmina can inform manufacturing economics, but their much larger scale and different product mixes make direct consolidated margin comparisons misleading. OSI’s higher Optoelectronics margin likely reflects engineered content and internal sales, not universal superiority in contract manufacturing.

Verdict: Security screening offers durable need, meaningful certification barriers, and valuable aftermarket economics. The disconfirming evidence is equally structural: procurement and site deployment are slow, contract concentration is meaningful, and better funding attracts strong competitors. OSI’s opportunity is large enough to support growth, but industry growth does not guarantee prompt revenue or stable returns.

Competitive Position

OSI’s defensible advantage is a system of complementary capabilities rather than a single patent. Rapiscan supplies multiple screening modalities; S2 designs, installs, and operates checkpoints; CertScan integrates equipment and data; Optoelectronics supplies selected internal components; and a global field organization supports the installed base. In RF, acquired engineering and new capacity broaden the Security portfolio into mission-critical transmission and surveillance.

The economic mechanism is integration-risk reduction. A customer can hold one provider responsible for equipment, workflow, uptime, software, training, and service. If that advantage is genuine, it should manifest in tender wins, installed-base growth, service attachment, renewal, price realization, margin, and cash returns. A broad product catalog alone is not a moat.

Brand and reputation

Brands matter economically in Security and Healthcare when they summarize reliability, regulatory history, and customer references. Rapiscan’s value is not mass-market awareness; it is procurement confidence that equipment can qualify, operate at a live site, integrate into workflow, and remain supported. Spacelabs can benefit when clinicians know its interface and hospitals have compatible monitoring infrastructure. In Optoelectronics, customer-specific qualification and quality history matter more than general brand recognition. [S1] [S6]

Financial evidence is strongest for Rapiscan. Security supplied most segment profit and earned a high-teens adjusted margin. Service grew faster than product revenue and carried materially better gross margin. The evidence is weak for a broad Spacelabs moat because Healthcare revenue declined and annual profitability remained low. If brand and workflow switching costs were powerful, Healthcare should eventually demonstrate better retention, pricing, and returns. [S1] [S2]

Nature of competition

Competition is based on detection and image quality, false-alarm rates, throughput, uptime, safety, certification, cybersecurity, total ownership cost, local content, financing, installation execution, interoperability, references, service coverage, and price. Leidos offers competing computed-tomography equipment, automated workflow, open-architecture software, and global service. Smiths has a large aviation installed base and substantial aftermarket revenue. Nuctech competes aggressively in international cargo and border systems. A narrower competitor can be superior in a specific modality even if OSI has broader system coverage. [S8] [S10] [S12]

OSI’s breadth is valuable when customers prefer one accountable integrator or need multiple inspection technologies. It can also increase organizational complexity, research requirements, and manufacturing overhead. The moat must therefore be evaluated after the costs of maintaining product breadth, service capacity, certifications, and working capital.

Switching costs

Switching costs are moderate to high after deployment but lower before procurement. Customers changing an installed system may face recertification, retraining, spare-parts changes, software integration, cybersecurity review, workflow redesign, downtime, and a new service relationship. Turnkey operators are more deeply embedded because they may provide staff and manage the full inspection process. Hospitals face clinician familiarity and network-integration costs. OEM customers must qualify replacement component or manufacturing suppliers. [S1] [S10]

These costs do not guarantee pricing power. Government buyers rebid contracts, demand interoperability, retain termination rights, and can replace a fleet during a regulatory upgrade. Large OEMs can dual-source. Hospitals may standardize on a larger rival during a capital refresh. The correct economic test is whether retention and price exceed the cost of service and incremental capital, not whether switching is merely inconvenient.

Installed base and scale

Management reports more than 100,000 installed Security systems and claims the leading global position in cargo and vehicle non-intrusive inspection. The installation count supports replication difficulty: a challenger would need product breadth, certifications, references, technicians, spare parts, and customer trust. It does not establish monopoly economics, and independent market-share data were not disclosed. Smiths’ scale and Leidos’ installed systems demonstrate that OSI is one of several meaningful incumbents. [S6] [S8] [S10]

The service evidence is encouraging. Consolidated service revenue reached $441.3 million, grew 13.2%, and earned a 43.8% gross margin. Management expects double-digit fiscal 2027 service growth and received a $50 million North American maintenance order in June 2026. The caveat is classification: consolidated service includes aftermarket work, installation, staffing, and turnkey operation. Installation attached to a new equipment project is less recurring than maintenance, while vendor-operated checkpoints may require upfront assets and receivable financing. [S1] [S4] [S6]

Vertical integration and cost position

Optoelectronics supplies internal components and operates lower-cost international facilities. Potential advantages include supply assurance, faster design feedback, quality control, procurement leverage, and shorter development cycles. External customers expose factories to demanding OEM qualifications and help absorb overhead. The segment’s 12.8% pre-charge margin is consistent with differentiated engineering rather than only commodity assembly. [S1]

The disconfirming evidence is the cost and complexity of maintaining 23 manufacturing sites and 13 research centers by management’s count. Internal transfer pricing obscures arm’s-length economics. Tariffs, logistics, underutilization, local-content requirements, and quality failures can eliminate labor-cost savings. Vertical integration adds value only if it improves consolidated delivery, innovation, margin, or cash return.

Patents, know-how, and regulation

The filing indicates that expiration of an individual patent generally should not be material. That implies the competitive advantage rests more on accumulated know-how, system integration, certification, service infrastructure, trademarks, and customer relationships than on one blocking patent. This is potentially durable because it spreads the moat across an organization, but it also makes measurement indirect. [S1]

A regulatory moat can weaken if standards change faster than OSI’s products, a rival secures qualification first, or governments insist on open architecture. Conversely, the installed service organization and historical tender record become more valuable when compliance grows more complex. Monitoring should focus on certifications won, tender win rates, service attachment, research intensity, and Security margin—not management’s qualitative leadership language.

Verdict: OSI appears to possess a meaningful Security moat and a narrower consolidated moat. The strongest proof is Security profitability and higher-margin service growth. The weakest element is Healthcare. The moat thesis would deteriorate if service growth trails products, major renewals or tenders are lost, Security margins compress persistently, or cash returns fail to compensate for turnkey capital.

Growth History and Forward Opportunities

Revenue grew from $1.147 billion in fiscal 2021 to $1.786 billion in fiscal 2026, a five-year compound rate of approximately 9.2%. Annual growth was uneven: 3.2% in 2022, 8.0% in 2023, 20.4% in 2024, 11.3% in 2025, and 4.3% in 2026. Fiscal 2024-2025 benefited heavily from the Mexican turnkey program; fiscal 2026 absorbed an approximately $150 million decline in Mexico revenue. The history demonstrates real scale growth but also warns against extrapolating peak project years. [S1] [S4] [S18]

The outlook for products and services is positive but compositionally uneven: Security service, cargo inspection, aviation replacement, and RF offer the best opportunities; Optoelectronics should grow with qualified OEM programs; Healthcare requires a margin and product-cycle recovery before it deserves meaningful growth value. [S2] [S4] [S6]

Security service and software

Service is the highest-quality stated growth vector. An expanding installed base supports maintenance, repair, training, upgrades, consumables, integration, and potentially software subscriptions. Fiscal 2026 service revenue increased 13.2% while product revenue rose 1.6%. Management expects strong double-digit service growth in fiscal 2027 and is expanding direct service in selected regions. CertScan can add data and workflow value across OSI and third-party equipment. [S1] [S4] [S6]

The missing evidence is economically important. Public reporting does not separate recurring maintenance from installation, training, staffing, or turnkey operations. Nor does it disclose renewal rates, software annual recurring revenue, service gross retention, or matched returns on vendor-operated sites. A higher service mix should raise confidence in revenue resilience and gross margin before it raises confidence in ROIC.

Border and cargo inspection

CBP’s incomplete deployment, higher scanning objectives, and identified future procurements support a multi-year equipment and service runway. OSI received two five-year sole-awardee IDIQ contracts with $200 million and $85 million ceilings. Management disclosed approximately $21 million of associated orders and expected most potential revenue after fiscal 2027. The combined $285 million ceiling is evidence of eligibility and addressable demand, not booked revenue. Only funded task or delivery orders should enter backlog or forecasts. [S4] [S11]

International demand benefits from customs modernization, drug interdiction, trade growth, and equipment replacement. The bear case is that border sites frequently need civil works, utilities, permits, staffing, and customer acceptance. Those constraints can defer revenue and cash after an award, as the GAO record and Middle East delay demonstrate.

Aviation replacement

Airports and regulators are moving toward computed-tomography screening, automated threat recognition, improved tray systems, and integrated workflow. Smiths’ fiscal 2025 aviation and aftermarket growth confirms an active market while establishing a demanding competitive benchmark. OSI’s outcome depends on certification timing, win rate, throughput and detection performance, manufacturing capacity, and aftermarket attachment—not merely the existence of a replacement cycle. [S8] [S10]

Aviation opportunities can also be lumpy. A major airport or government framework may generate a large nominal award, but site readiness, installation scheduling, and customer acceptance govern recognition. Mature fleet replacements may temporarily favor hardware revenue before service revenue follows.

RF and defense

The September 2024 RF acquisition appears strategically important. Management described approximately $38 million of quarterly RF revenue by fiscal 2026, substantially above the acquired operation’s initial scale, and the business helped secure a $235 million over-the-horizon-radar award. A Dallas capacity expansion supports production. These facts validate product relevance and strategic fit. [S1] [S5]

They do not establish acquisition return. Acquired EBIT, free cash flow, cumulative development expense, contingent payments, program working capital, and expansion capital are not separately disclosed. The award remained undefinitized and not-to-exceed. Attractive revenue growth could still produce a weak return if final pricing is unfavorable, cost estimates rise, or new capacity is underutilized.

Optoelectronics and Healthcare

Optoelectronics has qualified exposure to defense, aerospace, medical, communications, and industrial programs, including a disclosed medical-OEM award of approximately $40 million. Customer qualification can support repeat production across a platform life. Risks include inventory corrections, customer concentration within individual programs, pricing, redesigns, and utilization of a multi-country factory base. [S5]

Healthcare’s opportunity rests on new monitoring products, diagnostic cardiology, connected-care software, accessories, supplies, and service. Management installed new leadership and characterized the business as having high contribution margins. Fiscal 2026 revenue and annual profit do not yet validate that description. The fourth-quarter adjusted margin of 10% may mark an inflection, but management cautioned against extrapolation. Evidence of recovery requires several quarters of renewed patient-monitoring growth and sustained mid-single-digit or better margins. [S1] [S2] [S4]

Fiscal 2027 expectations

Management guides to $1.875-$1.930 billion of revenue, representing 5.0%-8.1% growth, and adjusted EPS of $11.13-$11.49, representing 7.5%-11.0% growth. The plan is second-half weighted because of Middle East delivery timing, limited early IDIQ contribution, Mexico comparisons, and program schedules. Management did not provide a forecast GAAP EPS reconciliation because acquisition, restructuring, amortization, tax, and other adjustments are not predictable and could be material. [S2] [S4]

At the midpoint, revenue growth is approximately 6.6% and adjusted-EPS growth approximately 9.3%. That spread requires margin improvement, lower share count, or both. Investors should reconcile quarterly GAAP operating profit and diluted shares rather than accepting adjusted-EPS growth as proof of improved operating returns.

Verdict: Mid-to-high-single-digit consolidated growth is plausible, with service and RF capable of growing faster. The opportunity is supported by installed equipment, government need, and current awards. The principal uncertainty is conversion: IDIQ ceilings, backlog, an undefinitized RF award, and one strong Healthcare quarter cannot be converted mechanically into earnings or cash.

Financial Quality

Corrected multi-year performance

The audited income series is as follows. A material reconciliation is required: Company Financials’ standardized operating-income field corresponds to segment income before separately presented restructuring and related charges, while the table below uses the lower consolidated GAAP operating-income line from OSI’s filings. For fiscal 2026, those figures were $235.6 million and $219.0 million, respectively. [S1] [S7]

Fiscal 2022 net income included a $27.4 million sale-leaseback gain, so the increase from fiscal 2021 was not a clean operating comparison. Fiscal 2026 revenue rose 4.3%, but GAAP operating income increased only 0.7%, net income 3.4%, and diluted EPS 2.8%. Service mix helped; gross margin nevertheless declined from 34.3% to 33.2%, restructuring and related charges rose, and product mix shifted away from the Mexican program. [S1] [S18]

Earnings are above the pre-2023 cycle but not demonstrably at a synchronized cyclical peak: Security backlog is high, Mexico project revenue is normalizing, delayed Middle East work has not converted, RF is ramping, and Healthcare profitability remains depressed. The appropriate description is elevated consolidated earnings with offsetting segment cycles. A strong backlog reduces the probability of an immediate demand trough but says less about mix, margin, or cash timing. [S1] [S4]

GAAP and adjusted earnings

Fiscal 2026 GAAP operating income was $219.0 million and GAAP diluted EPS was $8.95. Management reported adjusted operating income of $253.3 million and adjusted EPS of $10.35. The operating bridge removed $16.6 million of impairment, restructuring, legal, acquisition, retirement, facility, and other charges plus $17.8 million of acquired-intangible amortization. The EPS bridge also reflected tax effects and a discrete tax benefit. [S1] [S2]

Some adjustment is defensible. Transaction costs, individual legal matters, and discrete tax events can make one period incomparable. The skeptical point is recurrence: impairment, restructuring, and related charges were $6.4 million in fiscal 2024, $5.3 million in fiscal 2025, and $16.6 million in fiscal 2026. OSI also remains an active acquirer. Assuming zero future restructuring and treating all acquired amortization as economically free would overstate normalized owner earnings.

A reasonable normalization begins with GAAP, adds back only the clearly nonrecurring portion of charges, and retains an economic cost for replenishing acquired technology and customer relationships. This produces a result below management’s adjusted operating income but above reported GAAP in a year containing unusual costs. The exact figure is an estimate rather than a reported fact.

Accounting conservatism

Accounting is broadly conventional and reasonably conservative in expensing $79.1 million of research and development, but bill-and-hold revenue, multi-element Security contracts, estimated standalone selling prices, and recurring non-GAAP exclusions require scrutiny. The auditor identified allocation of Security transaction prices among performance obligations as a critical audit matter. [S1]

Fiscal 2026 bill-and-hold revenue rose to $64.7 million from $19.1 million in fiscal 2025 and $5.5 million in fiscal 2024. Customers requested delayed shipment because of site readiness and delivery constraints. Revenue may be valid under transfer-of-control criteria, but the growth of bill-and-hold makes physical delivery, acceptance, and collection important corroborating evidence. It should not be labeled aggressive accounting without contract-level evidence; it should not be ignored when evaluating cash quality either. [S1]

OSI broadened the presentation of remaining performance obligations in fiscal 2026 to include contracts with original expected durations of one year or less and conformed the comparison. Management states that the change did not alter revenue recognition, results, or financial position. It is therefore a disclosure-scope change, not evidence of accelerated revenue.

ROIC and segment returns

Using fiscal 2026 GAAP operating income of $219.0 million, an assumed 21% cash tax rate, and average invested capital of approximately $1.48 billion—average debt plus equity less cash—produces an estimated accounting ROIC of about 11.7%. Company Financials’ standardized fiscal 2026 measure was 10.35% under its own conventions. Capitalizing a portion of historical R&D increases the denominator; adding back a defensible fraction of exceptional charges increases the numerator. Reasonable treatments imply normalized ROIC of approximately 10%-12.5%. This is an analyst estimate, not a filed metric. [S1] [S7]

An assumed cost of capital of roughly 8.5%-9.5% implies a positive but modest spread. The conclusion is sensitive to project working capital, acquisition consideration, and whether research spending maintains existing economics or creates new products. OSI is not a business for which acquisition prices and repurchase discipline become irrelevant because reported accounting returns are overwhelmingly high.

Business profitability is attractive in Security, adequate in Optoelectronics, and poor in Healthcare; consolidated normalized ROIC is estimated at 10%-12.5%, only modestly above the likely cost of capital. Segment income before separately presented charges divided by year-end segment assets was approximately 13.2% for Security, 20.0% for Optoelectronics, and 2.2% for Healthcare. These are not formal ROIC figures: they use year-end gross assets, omit tax and corporate assets, and may include intercompany balances. They nevertheless show where reported economic strength resides. [S1]

Cash conversion

Net income and operating cash flow diverged sharply because the Mexican Security program and other projects moved receivables, unbilled revenue, inventory, and advances. Fiscal 2024 operating cash flow was negative $87.5 million despite $128.2 million of net income, principally because receivables consumed $293.6 million. Receivables consumed another $164.7 million in fiscal 2025. In fiscal 2026, receivables supplied $98.7 million and operating cash flow reached $275.9 million. [S1]

Net income is not proven to be structurally detached from cash, but the three-year shortfall is material: fiscal 2024-2026 cumulative operating cash flow was $286.0 million versus $432.5 million of net income because project working capital had not fully reversed. Management said the major Mexican receivable fell to approximately $190 million after $159 million of fourth-quarter collections and expects a significant further decline during fiscal 2027. That is a management forecast to test against subsequent balance sheets. [S4]

Free cash flow after ordinary capital expenditure was $245.3 million in fiscal 2026. The comparable three-year total was only $209.5 million, or $69.8 million annually. Neither endpoint is a reliable run rate. A normalized estimate of $150-$190 million allows for continued collections, ordinary inventory and receivable requirements, $30-$40 million of capital expenditure, and no repetition of the entire fiscal 2026 working-capital release. The range remains unusually uncertain because OSI has not disclosed matched cash returns for major project cohorts.

Capital intensity and economic obligations

Ordinary manufacturing capital expenditure was $30.6 million, only 1.7% of fiscal 2026 revenue and below $42.7 million of depreciation and amortization. That makes fixed-asset intensity look modest. The business is moderately capital-intensive in factories but can become highly working-capital-intensive when large turnkey Security projects require inventory, installation, customer acceptance, and sovereign receivable financing. R&D was another $79.1 million, or 4.4% of revenue, and represents economic reinvestment despite being expensed. [S1]

Capital intensity should therefore be assessed through four channels: ordinary capex, R&D, acquisitions, and project working capital. A service or turnkey contract can appear asset-light in the income statement while consuming equipment, civil works, staffing, bonds, or receivables.

Material off-balance-sheet or quasi-debt obligations include $48.8 million of recorded operating-lease payment obligations, $95.8 million of letters of credit, performance bonds with approximately $102 million of maximum exposure, $18.1 million of contingent acquisition consideration, government termination exposure, and customary indemnities whose maximum loss may not be estimable. Leases are recognized under current accounting and are therefore not literally hidden, but they remain senior economic claims. [S1]

Balance sheet and liquidity

Cash increased from $106.4 million to $359.8 million in fiscal 2026, while total debt rose to approximately $1.001 billion. Net debt was $641.2 million, or 2.45 times unadjusted fiscal 2026 EBITDA of $261.6 million. Including operating-lease payment obligations increases the ratio to approximately 2.64 times. Management’s stated 2.1 times net leverage uses credit-agreement definitions and should not be confused with this simpler GAAP calculation. [S1] [S4]

The $350 million 2.25% convertible notes due 2029 convert at approximately $191.98. Principal is generally settled in cash, with conversion value above principal potentially settled in cash or shares; diluted EPS is affected when the average share price exceeds the conversion threshold. The $575 million 0.5% notes due 2031 convert at approximately $353.82. Low coupons reduce current interest expense but do not remove principal, refinancing, cash-settlement, or dilution risk. [S1]

The $725 million revolving facility had $629.2 million of availability at June 30, 2026 after letters of credit, and no revolver borrowings were outstanding. Debt maturities are concentrated around 2029-2031 rather than near term. Liquidity is therefore adequate, but gross debt and contingent conversion claims increase the importance of disciplined repurchases and reliable collections. [S1]

Verdict: Financial quality is above average in Security profitability and reported margin, but moderate in cash predictability and consolidated ROIC. Fiscal 2026 collections are favorable evidence, not a new baseline. The corrected GAAP series is less flattering than pre-charge operating-income fields, and the remaining return spread is not large enough to excuse poor project or capital-allocation decisions.

Capital Allocation

Reinvestment and uses of cash

Management allocates capital among R&D, facilities and RF capacity, project working capital, bolt-on acquisitions, and share repurchases. There is no regular dividend. Over fiscal 2024-2026, OSI generated approximately $209.5 million of cumulative free cash flow after ordinary capex, spent $112.1 million on business acquisitions, paid another $53.0 million for intangible and other assets, and repurchased $352.3 million of stock. The cash uses exceeded internally generated free cash flow and were supported by debt, employee-equity proceeds, and balance-sheet movements. [S1]

Free cash flow is substantial in a collection year but only moderate through the project cycle; management has prioritized acquisitions and repurchases over dividends, and fiscal 2026 repurchases exceeded reasonable estimates of recurring free cash flow. Management describes the allocation process as disciplined. The objective test is per-share value after including acquisition consideration, contingent payments, follow-on development, capacity, project working capital, and dilution.

Acquisition record

The most important recent acquisition was the September 2024 purchase of a military, space, surveillance, and RF provider for approximately $76 million in cash plus up to $24 million of contingent consideration. Recognized consideration was approximately $85.7 million, including $30.7 million of goodwill and $47.3 million of intangible assets. Management subsequently described roughly $38 million of quarterly RF revenue and linked the platform to the $235 million over-the-horizon-radar award. [S1] [S5]

The record is promising but incomplete. If the business sustains approximately $150 million of annual revenue at a mid-teens operating margin, the initial purchase price could prove attractive before follow-on investment. However, OSI does not disclose acquired EBIT, cash flow, working capital, capacity capital, cumulative development spending, or final UCA economics. Significant acquisitions have expanded RF, security services, engineering, and manufacturing, but disclosed asset-level returns are insufficient to prove that the program as a whole has exceeded the cost of capital. [S1]

A June 2026 airport-screening-services acquisition required about $27 million upfront plus up to $14 million of contingent consideration. Recognized consideration was approximately $36.7 million, including $21.9 million of goodwill and $12.5 million of intangibles. Smaller transactions added engineering, structural components, contract manufacturing, and radiation-detection capabilities. Their individual operating contributions are not separately disclosed. [S1]

Acquisition accounting creates an important return discipline. It can be reasonable to remove one-time transaction costs from normalized profit, but the purchase price, contingent consideration, development, integration, and capacity spending must remain in invested capital. Otherwise, acquired growth is treated as costless.

Repurchases, converts, and share count

Fiscal 2025 repurchases totaled 531,314 shares for $80.4 million, approximately $151.41 per share. Fiscal 2026 repurchases totaled 1,111,825 shares for $271.9 million, approximately $244.55 per share. The fiscal 2026 tranches included 546,945 shares at $267.03 and 564,880 at $218.82. At $199.95, the fiscal 2026 average is approximately 22% above market, representing an unrealized opportunity-cost difference near $50 million. [S1] [S4]

The company is buying back shares aggressively, and the net result is real: period-end shares declined from approximately 17.055 million in fiscal 2024 to 16.794 million in fiscal 2025 and 15.918 million in fiscal 2026 despite employee issuance. The criticism is therefore not that buybacks failed to reduce the count. It is that fiscal 2026 purchases were made at prices above the current market while gross debt increased materially. [S1]

The $575 million convert was not legally earmarked dollar-for-dollar to individual repurchases, so saying every repurchased share was directly debt-funded would overstate traceability. The filing says proceeds were used for purposes including repayment of revolver borrowings, repurchases, investment, and taxes. Economically, simultaneous debt issuance and repurchases increased leverage relative to a no-buyback alternative. A low coupon does not settle whether the shares were acquired below intrinsic value.

The August 2026 authorization added one million shares and left approximately 1.08 million available, about 6.8% of fiscal year-end shares. Future repurchases should be judged against contemporaneous value and leverage, not simply their EPS accretion.

Stock compensation and insider transactions

Stock-based compensation was $26.4 million in fiscal 2026, approximately 1.5% of revenue and down from $32.0 million. Employees received shares through restricted-stock vesting and the employee stock-purchase plan, while tax withholding reduced issued shares. The expense is material but smaller than at many software companies, and net repurchases more than offset issuance over the last two fiscal years. [S1]

The company issues stock to insiders through performance RSUs, ordinary vesting, and the employee purchase plan, but net repurchases have more than offset issuance over the last two fiscal years. Recent Forms 4 require transaction classification. Executive Chairman Deepak Chopra sold 20,000 shares on May 4, 2026 at a weighted average $281.84 under a Rule 10b5-1 plan adopted in March 2025. The prearranged sale should not be presented as a new discretionary reaction to May results. Chief Executive Ajay Mehra acquired 75 shares at $140.61 through the employee purchase plan, transaction code A rather than open-market code P. It is not evidence of a discretionary insider purchase. [S14] [S15]

The reviewed recent ownership filings otherwise showed awards, vesting, withholding, or routine transactions rather than verified open-market executive purchases. Absence of such buying is not automatically bearish, but it removes a potentially favorable signal.

Compensation and governance

The latest available proxy tied annual incentives to adjusted return on equity. The fiscal 2025 target was 24.35%, with maximum payout beginning at 25.25%; reported achievement was 25.31%. Long-term performance awards were weighted 20% to revenue CAGR and 80% to GAAP operating-income CAGR, with target vesting at 5% and 7%, respectively. Executives are subject to five-times-salary ownership guidelines, clawback provisions, and anti-hedging and anti-pledging policies. [S3]

The compensation policy favors growth and accounting return on equity but omits free cash flow, ROIC, leverage, and relative shareholder return from the core metrics. That creates a potential incentive problem: debt-funded repurchases can reduce equity and mechanically raise ROE even when enterprise value creation is mediocre. Using GAAP operating income for long-term awards is more conservative than using adjusted EBIT, but revenue and EBIT growth can still reward acquisitions that fail to earn their cost of capital. [S3]

Management’s motivations appear growth-oriented and ownership-aware, but the combination of founder influence, family relationships, acquisition incentives, and an ROE-based annual metric warrants independent capital-allocation oversight. Ajay Mehra is Deepak Chopra’s first cousin. OSI owns 36% of ECIL-Rapiscan, while Mehra owns 4.5% and Chopra 10.5%; OSI’s share of earnings is immaterial, but overlapping interests remain a governance consideration. [S3] [S13]

Dividend policy

OSI has not paid a cash dividend since 1997 and states that it does not currently intend to pay one; credit agreements also contain restrictions. Dividend coverage is therefore not applicable. Shareholder cash return depends on discretionary, price-sensitive repurchases rather than recurring income. [S1]

Verdict: Capital allocation has produced real share-count reduction and a strategically promising RF platform. The disconfirming evidence is fiscal 2026 repurchase pricing, higher gross debt, incomplete acquisition-return disclosure, and an incentive framework that can reward leverage. Receivable collection and ROIC evidence should take priority over exhausting the new authorization.

Changes and Headwinds — Last Two Years

The operating environment changed materially during fiscal 2025-2026. Mexico moved from a major source of revenue growth and working-capital consumption to a revenue headwind and collection phase. RF became a meaningful defense platform. U.S. border funding and contract eligibility expanded. Middle East conflict delayed deliveries. Aviation replacement continued. Internally, OSI acquired capabilities, expanded RF capacity, changed segment leadership, increased debt, and transitioned from founder Deepak Chopra to Ajay Mehra as chief executive. [S1] [S4] [S11] [S13]

Mexico normalization

The Mexican turnkey program drove fiscal 2024-2025 growth and a severe receivables build. Fiscal 2026 Mexico revenue declined by nearly $150 million while collections improved. Management expects the remaining fiscal 2027 revenue headwind to be less than $25 million and concentrated in the first half. The key question has shifted from reported revenue to collection of the approximately $190 million remaining receivable, service continuity, and whether a replacement project recreates the same financing burden. [S4]

The program demonstrates why external demand and internal execution must be separated. The customer opportunity created revenue, but OSI’s contract structure, milestone execution, billing, and collection determined cash. A new large turnkey win can be operationally positive while initially depressing free cash flow.

Middle East delay

Fiscal fourth-quarter revenue declined 4% after approximately $50 million of planned Security deliveries moved beyond June because conflict and site-access constraints prevented completion. Management says the orders remain in backlog with revised schedules. This supports continuing demand but does not prove eventual timing, margin, or collection. Prolonged conflict could cause further delay, customer scope changes, cancellation, storage cost, or margin pressure. [S2] [S4]

Government funding and procurement

A Department of Homeland Security funding interruption affected procurement during fiscal 2026 and ended in April. Subsequent CBP IDIQ awards expanded OSI’s opportunity set. GAO evidence independently confirms substantial appropriations and deployment need, while also documenting years of site, staffing, construction, and testing delays. External funding sets the opportunity; internal bidding, production, installation, and collection determine OSI’s attributable profit and cash. [S4] [S11]

The distinction is essential. An appropriation supports customer capacity to spend. An IDIQ award establishes eligibility and a ceiling. A funded task order creates firmer executable volume. Backlog adds delivery visibility. Revenue and cash still require performance, acceptance, and payment.

RF strategy and facilities

The September 2024 RF acquisition, the $235 million UCA, and expanded Dallas capacity changed Security’s growth composition. The business now has more defense and program exposure, which can diversify cargo and aviation demand. It also adds cost-estimation, capacity-utilization, government-contract, and technical-milestone risk. [S1] [S5]

Facilities across Mexico and Asia provide labor-cost flexibility, while the expanded RF footprint supports a larger order pipeline. The economic test is whether incremental operating profit and cash exceed acquisition and expansion capital. Revenue scale alone is insufficient.

Leadership and governance

Ajay Mehra became chief executive on January 1, 2025 after leading Security. Founder Deepak Chopra moved to executive chairman and later chairman. The internal succession reduced product-learning risk and preserved customer continuity, but founder influence remains material. Optoelectronics leadership changed during 2025, and Healthcare added new leadership as management attempted to improve its margin. [S3] [S13]

Markets, facilities, and management all changed: border and RF demand strengthened, Mexico and Middle East timing weakened near-term sales, Dallas RF capacity expanded, and Ajay Mehra succeeded founder Deepak Chopra as CEO. The transition coincided with record backlog and a major collection year, but also with more debt and aggressive repurchases. Causality should not be assigned entirely to either leader.

Regulation, litigation, and accounting

Fiscal 2026 impairment, restructuring, and related charges increased to $16.6 million and included employee termination, acquisition, impairment, facility, legal, retirement, and divisional items. The company reported effective internal controls and received an unqualified audit opinion. [S1]

No material accounting-policy change altered reported results; the main disclosed change was broader remaining-performance-obligation presentation, while revenue recognition continued to depend on transfer of control, service performance, and estimated allocation among contract obligations. Bill-and-hold balances and the auditor’s Security revenue critical-audit matter remain monitoring points rather than evidence of a misstatement. [S1]

Verdict: External demand improved, but the company transitioned from one unusually large program into a more diversified and timing-sensitive mix. Internal acquisitions and service investment broadened opportunity; internal capital allocation increased financial risk. The last two years are neither uniformly favorable nor adverse—backlog and RF improved while cash concentration, geopolitical delay, debt, and restructuring became more important.

Risk Analysis

The most likely factors that could cause the stock to decline are another backlog-conversion delay, weak cash collection, Security margin compression, unfavorable RF definitization, continued debt-funded repurchases, or guidance showing that fiscal 2027 growth was more second-half-dependent than investors assumed. Multiple contraction would amplify any operating miss because the shares still trade above distressed or low-quality industrial valuations. [S1] [S2] [S4]

A severe drawdown need not require revenue collapse. A combination of flat Security revenue, a two-point segment-margin decline, weaker cash conversion, and a reduction from roughly 18 times to 15 times forward adjusted earnings could plausibly produce a 25%-40% equity decline. Convert dilution or higher refinancing costs could increase the effect.

A catastrophic investment loss would require several risks to compound: a major screening or cybersecurity failure causing liability or debarment, sovereign receivable losses, cancellation or loss-making execution of major contracts, and impaired capital-market access around debt maturities. Medical-device failure creates a separate recall and liability channel. [S1]

A literal total loss is remote because OSI has profitable operations, approximately $360 million of cash, a valuable installed base, diversified customers, and long-dated debt. The plausible route would require fraud or systemic product failure, debarment from core government markets, large uninsured judgments, major receivable losses, and inability to refinance or sell assets. No current evidence indicates that combination. A severe but non-total permanent loss from overvaluation, leverage, and execution is substantially more plausible. [S1]

Other downside interpretations deserve explicit weight. Backlog may contain lower-margin work or distant deliveries. Service growth may be dominated by installation rather than recurring maintenance. Management’s adjusted results remove categories that recur in an acquisition-led company. Optoelectronics repeat revenue remains exposed to OEM cycles. Founder and family relationships may reduce perceived independence even where formal controls exist.

Offsets include mandatory security applications, incomplete border deployment, geographical and customer diversification, service margins, substantial liquidity, and recoverable working capital. These offsets reduce near-term insolvency risk; they do not make the equity insensitive to purchase price.

Verdict: The dominant risk is not immediate solvency. It is paying a quality multiple for earnings and cash that remain project-timed and dependent on capital allocation. Catastrophic loss is low probability, while a 25%-40% drawdown under adverse execution is credible.

Valuation Discussion

Current snapshot

At $199.95 and 15.918 million fiscal year-end shares, estimated basic equity value is $3.183 billion. Adding $641.2 million of net debt produces enterprise value of approximately $3.824 billion before leases. Including recorded operating-lease payment obligations raises adjusted enterprise value to roughly $3.873 billion. These are analyst calculations using the current price and audited balance sheet, not vendor-reported market values. [S1] [S7]

The two free-cash-flow endpoints are deliberately shown together. Treating the 7.7% reported yield as recurring would capitalize a working-capital release. Treating the three-year average as permanent would assume the remaining project receivable never converts. The normalized range is more balanced but has lower evidentiary confidence than the P/E and EV calculations.

At fiscal year-end prices, Company Financials’ historical diagnostics placed GAAP P/E from roughly the low teens in fiscal 2022 to the mid-20s in fiscal 2025. Business mix and earnings quality changed across that period, so historical percentiles do not establish intrinsic value. They indicate that the current valuation is below the recent peak but not at a clear trough. [S7]

Peer and transaction framing

No public company is a clean consolidated peer. Smiths Detection is the closest security-screening operating comparator. Leidos competes directly in aviation security but is primarily a government-services and technology contractor. Jabil and Sanmina illuminate manufacturing economics but have different scale and mix. Teledyne offers high-value sensing and electronics with broader instrumentation. Large medical-device companies are disproportionate comparisons for a division representing only 9.1% of OSI revenue.

The completed Smiths Detection sale is the cleanest external marker. CVC acquired the business for £2.0 billion of enterprise value, equivalent to 12.5 times fiscal 2025 headline EBITDA and 16.3 times headline operating profit, for a business with £963 million of revenue, a 12.7% headline operating margin, and 51% aftermarket revenue. Completion on June 30, 2026 removes the draft’s stale transaction-closing uncertainty, but the sale still does not create an automatic valuation floor for OSI. [S8] [S9]

OSI’s 14.6 times consolidated EBITDA is higher. Potential justification includes Security’s higher segment margin, RF growth, and profitable Optoelectronics. Offsets include weaker Healthcare, more visible project working capital, greater leverage after repurchases, and uncertainty over service composition. The Smiths benchmark supports strategic value in Security assets while leaving room for consolidated OSI to trade below or above it depending on growth and cash quality.

Broad standardized snapshots can place Jabil, Sanmina, Leidos, and Teledyne at materially different multiples, but their structures make a simple peer median unreliable. A sum-of-the-parts framework is directionally better: apply a premium industrial-security value to sustainable Security earnings, a lower engineered-manufacturing value to Optoelectronics, and little premium to Healthcare until its margin recovers; then subtract net debt and conversion claims.

Sanmina’s same-industry report is most useful as a warning against valuing repeat OEM revenue as though it were a proprietary annuity. Its company-specific issues—thin assembly margins, concentrated customer programs, acquisition-related working capital, and the need to separate revenue scale from attributable profit—are not OSI facts. Revalidated against OSI’s filings, however, they reinforce using Optoelectronics’ 12.8% segment margin, intersegment activity, cash requirements, and qualification economics rather than an electronic-components peer median. [S1]

Scenario analysis

The scenarios are analyst estimates beyond fiscal 2027 guidance. They use fiscal 2028 because the second-half-weighted 2027 plan, Middle East conversion, CBP ordering, and RF execution require more than one quarter to evaluate.

The bear case assumes approximately 4.5% compound revenue growth from fiscal 2026, repeated Middle East or government delays, slow CBP task orders, Security margin erosion, weak Healthcare, and conversion dilution that more than offsets employee-share repurchases. It assumes normalized free cash flow near $120-$140 million and a lower terminal multiple because working capital remains structural. Revenue does not collapse; the downside comes from lower margin, cash quality, and valuation.

The base case assumes approximately 9.7% compound growth through fiscal 2028, including conversion of delayed deliveries, double-digit service growth moderating over time, RF execution without a material loss, and modest Healthcare improvement. GAAP operating margin reaches 14% as fiscal 2026 charges normalize and mix improves. Free cash flow approaches $180-$210 million after Mexico collections, and repurchases roughly offset employee issuance rather than producing another debt-funded reduction. An 18.5 times P/E reflects a better-than-average Security franchise but retains a discount to premium compounders.

The bull case assumes approximately 13.5% compound revenue growth, concurrent strength in service, border, aviation, and RF, high-teens Security adjusted margins, Healthcare recovery, and favorable working-capital conversion. Free cash flow exceeds $230 million, allowing deleveraging and selective repurchases. A 22 times multiple requires demonstrated recurring-service economics and durable ROIC, not simply a larger backlog.

A 25% bear, 50% base, and 25% bull weighting produces an illustrative value of approximately $237. The $235 twelve-month target rounds that distribution and allows for execution risk. The $175 preferred entry is approximately 25% below the target and creates more protection against the bear case than the current price.

Reverse expectations

At the present enterprise value, a reverse valuation using an assumed 9% cost of capital and 3% terminal growth requires normalized free cash flow materially above the fiscal 2024-2026 average and sustained mid-single-digit or better growth. In operational terms, the price embeds delivery of fiscal 2027 guidance near the midpoint, a substantial Mexico collection, no material loss upon RF definitization, continued service growth, and eventual GAAP margin expansion.

The market gets several points right: security demand is durable, the backlog is meaningful, the service mix is improving, and liquidity is adequate. Fragile assumptions are that project schedules normalize, service growth carries maintenance-like capital intensity, Healthcare stops diluting returns, and buybacks do not destroy value. The current price no longer embeds the April high’s combination of rapid growth and a premium multiple, but it still embeds successful conversion.

Verdict: Valuation is reasonable rather than compelling. The reset has removed much of the prior excess, but most upside requires margin and cash validation. The bear case can occur without a collapse in demand because lower conversion, dilution, and multiple compression are sufficient.

Variant Perception

The apparent consensus is that OSI is a differentiated small-cap industrial-technology compounder benefiting from border security, aviation replacement, defense, and higher-margin service. The $1.9 billion backlog and fiscal 2027 adjusted-EPS guidance support that view. The 2026 drawdown indicates that investors no longer grant full credit for every order headline, but the remaining valuation still assumes above-average franchise quality.

The strongest bull case is that Security should be valued as a certified installed-base and service platform rather than an equipment contractor. On that interpretation, fiscal 2026’s low growth reflects a Mexico comparison; Middle East revenue is delayed, not lost; CBP funding and RF provide a second growth leg; and Mexico collections release cash for deleveraging. Smiths Detection’s completed sale corroborates strategic demand for comparable assets. [S4] [S9] [S11]

The strongest bear case is that OSI remains a project contractor with volatile working capital, recurring exclusions, and concentrated sovereign receivables. Backlog may defer risk rather than remove it. Management borrowed at a low coupon but repurchased shares above the current market, while compensation emphasizes ROE and operating-income growth instead of ROIC and free cash flow. Healthcare remains a low-return appendage, and better-capitalized rivals can compete aggressively.

Investors on the latest calls focused on whether Middle East orders were delayed or lost, how much IDIQ ceiling value was actually ordered, whether service growth was sustainable, when Mexico receivables would convert to cash, whether Optoelectronics margins were repeatable, how repurchases affected EPS, when checked-baggage opportunities would arrive, and whether RF capacity could execute the $235 million award. Those questions are useful because each separates demand headlines from attributable cash returns. [S4] [S5]

Five load-bearing assumptions organize the debate:

1. Backlog quality. Bull evidence is recognition of delayed Middle East revenue without cancellation or margin erosion. Bear evidence is repeated rescheduling, higher bill-and-hold balances, falling funded backlog, or customer cancellation. [S1] [S4]

2. Service economics. Bull evidence is double-digit service growth with stable gross margin, disclosed renewal strength, and limited incremental capital. Bear evidence is growth dominated by installation or vendor-financed turnkey activity, lower margin, or another working-capital build. [S1] [S4]

3. RF returns. Bull evidence is prompt definitization, funded milestones, segment-margin stability, and cash contribution. Bear evidence is cost escalation, capacity underutilization, impairment, or a lower final contract value. [S4] [S5]

4. Capital allocation. Bull evidence is deleveraging and repurchases below conservative value. Bear evidence is continued repurchases above value while gross debt remains near $1 billion. [S1] [S3]

5. Healthcare recovery. Bull evidence is sustained mid-single-digit or better margin and renewed patient-monitoring growth. Bear evidence is recurring restructuring and near-zero annual profit. [S1] [S2]

Factor and positioning context

Positioning is not independently observable from the available ownership evidence. The factor model provides a dated statistical diagnostic, not a fundamental classification. As of September 11, 2026, estimated exposures included Market 1.146, SmallSize 0.644, Industrials 0.373, Consumer Staples -0.211, and Liquidity -0.186. Residual momentum was -0.028, residual Sharpe -0.681, and residual volatility 0.312. The model explained only 32.2% of historical variation and estimated near-zero alpha. [S17]

These exposures describe covariance, not causation. The Industrials exposure does not legally or economically classify the company, and the negative liquidity loading is not proof that liquidity caused the drawdown. The results suggest that broad market, small-company, industrial, and liquidity conditions can affect returns, while roughly two-thirds of variation remained unexplained. The factor model therefore cautions against attributing every move to management but neither validates nor refutes the fundamental thesis.

Revalidated learnings and contradictions

No prior dated OSI public report exists, so there is no inherited company recommendation or falsifier scorecard to update. Most retrieved biotechnology, utility, restaurant, marketplace, and other company-specific learnings are outside scope and should not be transferred to OSI.

Three retrieved principles survived revalidation. First, valuation must be recomputed after a large price gap; OSI’s decline materially changed forward P/E but did not create a distressed normalized-cash yield. Second, government capital availability, contract eligibility, funded task orders, backlog, revenue, and cash are distinct evidence tiers. Third, insider filings must distinguish open-market purchases from ESPP acquisitions, grants, withholding, and prearranged sales. [S4] [S7] [S11] [S14] [S15]

The primary contradictions are now explicit. Management-defined recurring or repeat revenue is not audited contractual recurrence. The $50 million Middle East amount is verified as management commentary but “not lost” remains a hypothesis. Fiscal 2026 free cash flow was strong, yet three-year conversion remained weak. The RF acquisition shows revenue scaling without disclosed return. The standardized operating-income field required correction to the lower GAAP line. A 10% Healthcare fourth-quarter adjusted margin conflicts with weak full-year economics and should not be treated as a run rate. Finally, the prior transaction-status assumption for Smiths Detection was stale: the £2.0 billion sale completed on June 30, 2026. [S1] [S2] [S4] [S7] [S9]

Verdict: The useful variant is not that security demand is secretly strong; that is visible. It is that demand has not yet been proven to convert into durable per-share cash returns at the present capital structure. The bull side wins if service cohorts, collections, and RF economics validate the backlog. The bear side wins if timing, working capital, exclusions, and repurchases continue consuming the apparent advantage.

Fact vs. Interpretation

The evidence hierarchy matters. Filed revenue, debt, cash flow, and repurchases are facts. Management commentary supplies testable hypotheses. Normalized cash flow, moat width, cost of capital, and intrinsic value are estimates or interpretations. The report does not promote any of the latter into reported fact.

Verdict: Evidence is strongest on reported scale, segment margins, debt, repurchases, and government deployment need. It is weaker on market share, recurring-service composition, acquired returns, and normalized free cash flow.

Open Questions

1. What was the exact June 2026 aging and contractual payment schedule of the Mexican receivable, and how much has been collected since year-end? Management disclosed an approximately $190 million balance but not a complete aging schedule. [S1] [S4]

2. Of fiscal 2026’s $441.3 million service revenue, how much was maintenance, subscription software, installation, training, staffing, checkpoint operation, and other project work—and what were the retention, margin, capex, and working-capital characteristics of each? [S1] [S6]

3. When will the $235 million RF UCA be definitized, how much is funded, what cost-escalation protection exists, and what additional capacity investment is required? [S4] [S5]

4. What minimum intrinsic-value discount, ROIC, or leverage threshold governs repurchases under the expanded authorization? Fiscal 2026 purchases averaged materially above the current price. [S1] [S3]

5. What acquired revenue, EBIT, free cash flow, contingent payments, development expense, and capacity capital are attributable to the September 2024 RF acquisition? [S1] [S5]

6. Why should Healthcare remain in the portfolio if normalized returns stay below the cost of capital, and what margin threshold or deadline governs that decision? [S1] [S4]

7. What portion of the $1.9 billion backlog is expected beyond twelve months, is fixed price, requires customer acceptance, contains termination rights, or requires material working-capital funding? [S1]

8. Will the next compensation framework incorporate free cash flow, leverage, or ROIC so that acquisition and repurchase activity cannot raise incentive payouts without creating enterprise value? [S3]

9. How much of the two CBP IDIQ ceilings is supported by funded orders beyond the approximately $21 million disclosed, and what site-readiness assumptions underlie expected revenue timing? [S4] [S11]

These questions seek missing economic inputs, not promotional detail. Their answers determine whether OSI is merely an attractive portfolio of products or an attractive security at the current price.

What Must Be True

Bull tests

• Backlog converts: most of the approximately $50 million of delayed Middle East work is recognized by fiscal 2027 year-end without material cancellation or margin erosion, while backlog remains at least $1.8 billion after conversion. [S1] [S4]

• Cash conversion normalizes: fiscal 2027 operating cash flow exceeds net income, free cash flow exceeds $180 million, and receivables do not grow faster than revenue. Management specifically expects free cash flow to exceed net income, making this a testable forecast rather than an analyst-created catalyst. [S1] [S4]

• Service quality improves: service revenue grows at least 10%, consolidated service gross margin remains above 42%, and management demonstrates that maintenance or software—not only installation—drives the increase. [S1] [S4]

• RF earns a return: the $235 million UCA is definitized without a material charge, funded milestones progress, and Security’s pre-charge margin remains at least 16% through the capacity ramp. [S4] [S5]

• Healthcare recovers: the division produces at least a 6% pre-charge margin over four consecutive quarters without another large excluded restructuring program. The threshold is deliberately above fiscal 2026’s 4.2% annual result but below the non-repeatable 10% fourth-quarter adjusted result. [S1] [S2] [S4]

• Capital allocation tightens: net debt falls below two times unadjusted EBITDA before another repurchase program comparable with fiscal 2026, and net share reduction occurs below a conservative estimate of value. [S1] [S3]

If these conditions occur together, investors can reasonably treat OSI as a service-enhanced Security compounder rather than principally a project contractor.

Bear tests

• Backlog proves soft: Middle East deliveries slip again, material orders are cancelled, or backlog falls below $1.6 billion without equivalent revenue conversion. The premise is grounded in the current $1.9 billion backlog and documented delivery delay. [S1] [S4]

• Working capital remains structural: cumulative operating cash flow remains below 85% of cumulative net income over fiscal 2026-2028, or another customer exceeds 30% of receivables. The current three-year conversion deficit and 25% customer concentration make this a measurable test. [S1]

• Margins erode: Security’s pre-charge margin falls below 14.5% for a full year because of bidding, mix, or RF execution, while restructuring exclusions persist. The comparison point is fiscal 2026’s verified 16.7% Security margin. [S1]

• RF economics disappoint: definitization reduces expected contract value, estimated costs rise materially, or capacity produces underutilization and impairment. The award’s undefinitized, not-to-exceed status makes these genuine risks rather than generic warnings. [S4] [S5]

• Buybacks transfer value away: the board increases net debt or spends more than normalized free cash flow on repurchases while shares trade above 20 times forward adjusted EPS. Fiscal 2026’s $271.9 million repurchase program and higher debt establish the precedent. [S1] [S3]

• Healthcare remains subscale: revenue declines and the pre-charge margin remains below 4% through fiscal 2027, indicating that the segment has neither recovered nor been rationalized. [S1] [S2]

• Competitive advantage weakens: service growth falls below product growth, major maintenance renewals or tenders are lost, or Security research spending rises without corresponding win rates and margins. [S1] [S8] [S10]

The monitoring sequence should remain disciplined. First, reconcile receivables, unbilled revenue, and cash collection each quarter. Second, separate appropriations, IDIQ ceilings, funded orders, and backlog. Third, compare service growth with gross margin and capital employed. Fourth, track RF funding, definitization, milestone acceptance, and charges. Fifth, evaluate each repurchase against leverage and contemporaneous value. The thesis is falsified by cash and return evidence, not by one quarter of revenue noise or one contract headline. [S1] [S4] [S11]

Verdict: The equity works if service, collections, and RF convert visible demand into repeatable per-share cash returns while leverage declines. It fails if backlog remains impressive but capital continues accumulating in receivables, acquisitions, capacity, and above-value repurchases.

Linked sources

• S1 — OSI Systems fiscal 2026 Form 10-K
• S2 — Fiscal 2026 fourth-quarter and full-year results
• S3 — OSI Systems 2025 definitive proxy statement
• S4 — OSI Systems earnings-call archive
• S5 — OSI Systems earnings-call archive
• S6 — September 2026 investor presentation
• S7 — Company Financials and OSI stock information
• S8 — Smiths Group fiscal 2025 results
• S9 — Completion of Smiths Detection sale
• S10 — Leidos security-detection portfolio
• S11 — GAO report on vehicle scanning at land ports
• S12 — European Commission investigation concerning Nuctech
• S13 — OSI Systems CEO succession Form 8-K
• S14 — Deepak Chopra Form 4
• S15 — Ajay Mehra Form 4
• S16 — OSI Systems SEC filing history
• S17 — The factor model dated snapshot
• S18 — OSI Systems fiscal 2023 Form 10-K

Public source appendix

• S1: OSI Systems fiscal 2026 Form 10-K — primary filing; published 2026-08-21; Items 1, 1A, 7, 7A, 8 and 9A; consolidated statements; revenue, acquisitions, debt, leases, commitments, segments, stock compensation, and repurchase notes
• S2: OSI Systems fiscal 2026 fourth-quarter and full-year results — primary company release; published 2026-08-20; Financial Summary, Fiscal Year 2027 Outlook, GAAP and non-GAAP reconciliations, and segment tables
• S3: OSI Systems 2025 definitive proxy statement — primary proxy filing; published 2025-10-22; Corporate governance, related-party interests, ownership requirements, annual AROE incentive, and performance-RSU metrics
• S4: Company Financials — OSI Systems fiscal 2026 fourth-quarter earnings call — management transcript via Company Financials; published 2026-08-20; August 20, 2026 prepared remarks and Q&A on Middle East deliveries, service, Mexico collections, IDIQs, RF, cash flow, Healthcare, leverage, and guidance
• S5: Company Financials — OSI Systems fiscal 2026 third-quarter earnings call — management transcript via Company Financials; published 2026-05-04; May 4, 2026 prepared remarks and Q&A on Mexico, DHS funding, RF, service growth, Optoelectronics, Healthcare, aviation, and capacity
• S6: OSI Systems September 2026 investor presentation — primary company presentation; published 2026-09-03; Pages 5-11, 22, and 29-30: segment and geography mix, recurring and repeat classifications, backlog, installed base, facilities, products, catalysts, and GAAP/non-GAAP reconciliation
• S7: Company Financials — OSIS profile, statements, prices, ratios, enterprise value, and valuation — third-party financial dataset; published 2026-09-14; NASDAQ:OSIS exchange-qualified primary symbol; multi-period financials and ratios; split-adjusted prices through September 14, 2026; material values reconciled to primary filings
• S8: Smiths Group fiscal 2025 results — Smiths Detection — primary competitor presentation; published 2025-09-23; Page 16: revenue, aftermarket mix, headline operating margin, aviation growth, and CTiX installed base
• S9: Completion of Smiths Detection sale — primary competitor transaction release; published 2026-06-30; Completion at £2.0 billion enterprise value; 12.5x fiscal 2025 headline EBITDA; 16.3x headline operating profit; more than £1.9 billion of immediate net cash proceeds
• S10: Leidos Security Enterprise Solutions overview — primary competitor product material; publication date unavailable; Security-detection products, open-architecture software, automated workflows, airport deployments, installed systems, and global service capabilities
• S11: GAO: Improvements Needed to Increase Vehicle Scanning at Land Ports of Entry — government report; published 2026-02-18; Funding, planned and operational system counts, scanning rates, deployment constraints, completion timing, and potential future procurement
• S12: European Commission investigation concerning potential Nuctech foreign subsidies — regulator release; published 2025-12-11; Preliminary concerns, potential subsidy mechanisms, tender effects, company description, and non-prejudgment language
• S13: OSI Systems CEO succession Form 8-K — primary filing; published 2024-12-13; Item 5.02: Ajay Mehra appointment, January 1, 2025 effective date, board change, employment terms, and family relationship
• S14: Deepak Chopra Form 4 — primary insider filing; published 2026-05-05; Table I and footnotes: 20,000-share sale at a $281.84 weighted average under a Rule 10b5-1 plan adopted March 12, 2025
• S15: Ajay Mehra Form 4 — primary insider filing; published 2026-07-01; Table I and footnotes: 75 shares acquired at $140.61 through the employee stock-purchase plan, transaction code A
• S16: OSI Systems SEC filing history — primary regulatory index; publication date unavailable; Trailing 60-month filing index reviewed for Forms 10-K, 10-Q, material 8-K, proxy statements, and relevant Forms 3, 4, and 5
• S17: The factor model — OSIS dated snapshot — quantitative diagnostic; published 2026-09-11; Exposures, residual signals, alpha, R-squared, and diagnostics as of September 11, 2026
• S18: OSI Systems fiscal 2023 Form 10-K — primary filing; published 2023-08-29; Fiscal 2021-2023 audited statements, segment reconciliation, cash flows, and fiscal 2022 sale-leaseback gain